top of page

Autoimmune and Cancer Information

images.jpeg

Link Between Vulvar Lichen Sclerosus (VLS) and Autoimmune Diseases

  • Strong Correlation with Autoimmune Diseases

    Autoimmune diseases are significantly associated with VLS, with shared immunological mechanisms underlying both conditions.

    • Research by Tran et al. (2019) identified that over 30% of individuals with VLS also have autoimmune thyroid dysfunction, such as Hashimoto’s thyroiditis or Graves’ disease.

  • Autoantibodies Against ECM1

    A hallmark of VLS is the presence of autoantibodies targeting extracellular matrix protein 1 (ECM1).

    • Günthert et al. (2008) demonstrated that these autoantibodies disrupt the dermal-epidermal junction, contributing to the characteristic tissue thinning and sclerosis observed in VLS.

  • Prevalence of Multiple Autoimmune Diseases

    Many patients with VLS exhibit more than one autoimmune condition.

    • Wilson et al. (2018) reported that 27% of VLS patients had coexisting conditions such as rheumatoid arthritis, lupus, or vitiligo, emphasizing the need for comprehensive health evaluations in this population.

  • Dormancy of Autoimmune Diseases

    Autoimmune conditions linked to VLS can remain dormant for extended periods, complicating early diagnosis.

    • Tran et al. (2019) noted that subclinical autoimmune activity might precede overt VLS symptoms by years, making it challenging to detect the condition in its early stages.

  • Clinical Implications

    The strong connection between VLS and autoimmune diseases highlights the need for routine screening and comprehensive care.

    • Tran et al. (2019) recommended thyroid function tests for newly diagnosed VLS patients, particularly those with a family history of autoimmune disorders.​​

squamous-cell-carcinoma-vulva.jpg

Link Between Vulvar Lichen Sclerosus (VLS) and Cancer

  • Increased Risk of Vulvar Squamous Cell Carcinoma (VSCC)

    VLS is associated with an elevated risk of developing vulvar squamous cell carcinoma (VSCC), particularly in long-standing, untreated cases.

    • Approximately 4% of women with VLS develop VSCC, according to Bleeker et al. (2016).

    • Chronic inflammation and scarring in VLS are believed to create a pro-inflammatory microenvironment that facilitates malignant transformation (Bleeker et al., 2016).

  • High-Risk Lesions and Predictive Indicators

    Certain characteristics of VLS lesions increase the risk of cancer:

    • Hyperkeratotic lesions are particularly prone to malignant transformation.

    • Singh et al. (2017) recommended routine biopsies for patients with persistent or atypical lesions to identify early neoplastic changes.

  • Importance of Early Diagnosis and Monitoring

    Regular follow-ups and vigilant monitoring of VLS are critical to mitigating cancer risks.

    • Bradford and Fischer (2010) highlighted that early and consistent use of clobetasol propionate reduces the risk of progression to malignancy.

    • Cooper et al. (2004) emphasized the role of maintenance therapy in preventing structural complications and lowering cancer risk.

  • Need for Continued Research

    There are still gaps in understanding the exact mechanisms linking VLS to VSCC, emphasizing the need for further studies on long-term outcomes and risk factors (Bleeker et al., 2016; Singh et al., 2017).

bottom of page